Table 4.

Comparison of FLC Immunoquantitative Data

Patient/Diagnosis*	Monoclonal Ig †	anti-FLC polyclonal antibodies‡			anti-FLC monoclonal antibodies§
		κ FLC∥¶	λ FLC∥¶	κ:λ FLC¶	κ FLC∥#	λ FLC∥#	κ:λ #
FLC¶
1/AL	IgGλ	1.1	10.9	0.10	0.6	27.7	0.02
2/MM	IgGκ	4.1	0.6	6.83	6.6	6.2	1.06
3/AL	IgGλ	1.2	1.9	0.63	1.3	50.5	0.03
4/AL	IgGκ	12.1	1.6	7.56	18.1	19.9	0.91
5/AL	BJPκ	101.0	0.2	505.0	141.5	4.1	34.51
6/AL	IgGλ/BJPλ	0.8	40.0	0.02	1.3	43.3	0.03
7/MM	IgGκ	68.1	0.26	261.9	27.2	2.8	9.71
8/MM/AL	BJPκ	39.1	4.20	9.31	282.1	25.6	11.02
9/MM	BJPλ	0.15	74.7	0.002	0.7	71.4	0.01
10/AL	IgAλ	0.62	8.1	0.08	0.7	217.3	0.003
11/AL	BJPλ	0.96	48.7	0.02	1.2	27.8	0.04
12/MM	BJPκ	35.8	1.1	32.5	35.5	6.0	5.92

^*AL, AL amyloidosis; MM, multiple myeloma.

^†Based on immunofixation electrophoresis.

^‡FREELITE™ anti-κ FLC and anti-λ FLC reagents.

^§anti-κ FLC (Fκ–C8) and anti-λ FLC (Fλ–G9) mAbs.

^∥mg/L.

^¶Normal values: κ, 3.3–19.4; λ, 5.71–26.3; κ:λ, 0.26–1.65.

^#Normal values: κ, 4.2–13.0; λ, 16.4–127.3; κ:λ, 0.07–0.28.